US 9266933
Polypeptides inhibiting neovascularization and uses thereof
granted A61KA61K38/1866A61K38/1891
Quick answer
US patent 9266933 (Polypeptides inhibiting neovascularization and uses thereof) held by SHANGHAI FIRST PEOPLE'S HOSPITAL expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SHANGHAI FIRST PEOPLE'S HOSPITAL
- Grant date
- Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/1866, A61K38/1891, A61K9/0048, A61P